Global Gene Synthesis Market Size, Share, Opportunities, And Trends By Type (Gene Library Synthesis, Custom Gene Synthesis), By Application (Synthetic Biology, Genetic Engineering, Vaccine Design, Therapeutic Antibodies, Others), By End Users (Pharmaceuticals and Biopharmaceutical Companies, Contract Research Organisations, Research Institutes) And By Geography - Forecasts From 2025 To 2030

Comprehensive analysis of demand drivers, supply-side constraints, competitive landscape, and growth opportunities across applications and regions.

Report CodeKSI061611929
PublishedSep, 2025

Description

Gene Synthesis Market Size:

The Gene Synthesis Market will surge from USD 2.304 billion in 2025 to USD 5.234 billion by 2030, fueled by a 17.83% CAGR.

Gene synthesis refers to the chemical, base-by-base in vitro synthesis of double-stranded DNA sequence that represents one or more genes. The technology has become a significant tool in in the areas of vaccine development, gene therapy, molecular engineering, and in development of recombinant DNA. Gene synthesis have also introduced the possibility of developing genes containing modified nucleotides or even novel base pairs that could allow for the expansion of the genetic code. The growth in the market may be attributed to the increasing investment in research and development in the field of genomics and next generation sequencing. Increasing Government interest and funding in the field of genomics will also positively impact the market. However, high cost and complexity of the gene synthesis techniques might hamper the growth of the market. Dearth of skilled professionals for the techniques might also restrain the market for gene synthesis during the given time frame.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global Gene Synthesis market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global Gene Synthesis market.

Major industry players profiled as part of the report are Evonetix, Genewiz and ATUM among others.

Segmentation

  • By Product Type & Service Type
    • Gene Synthesis Products
    • Gene Synthesis Services
    • Software & Bioinformatics Tools
  • By Technology
    • Solid-Phase Synthesis
    • Chip-Based Synthesis
    • PCR-Based Enzyme Synthesis
    • Others
  • By Gene Type
    • Standard Gene Synthesis
    • Complex Gene Synthesis
    • Codon-Optimized Genes
    • Others
  • By Application
    • Synthetic Biology
    • Genetic Engineering
    • Diagnostics & Therapeutics Development
    • Protein Engineering
    • Industrial Biotechnology
    • Others
  • By End-User
    • Pharmaceuticals and Biopharmaceutical Companies
    • Contract Research Organisations (CROs)
    • Academic & Research Institutes
    • Diagnostics Laboratories
    • Others
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Italy
      • Others
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Taiwan
      • Others

Table Of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK 

5.  GENE SYNTHESIS MARKET BY PRODUCT TYPE & SERVICE TYPE

5.1. Introduction

5.2. Gene Synthesis Products

5.3. Gene Synthesis Services

5.4. Software & Bioinformatics Tools

6. GENE SYNTHESIS MARKET BY TECHNOLOGY

6.1. Introduction

6.2. Solid-Phase Synthesis

6.3. Chip-Based Synthesis

6.4. PCR-Based Enzyme Synthesis

6.5. Others

7.  GENE SYNTHESIS MARKET GENE TYPE

7.1. Introduction

7.2. Standard Gene Synthesis

7.3. Complex Gene Synthesis

7.4. Codon-Optimized Genes

7.5. Others

8.  GENE SYNTHESIS MARKET BY APPLICATION

8.1. Introduction

8.2. Synthetic Biology

8.3. Genetic Engineering

8.4. Diagnostics & Therapeutics Development

8.5. Protein Engineering

8.6. Industrial Biotechnology

8.7. Others

9. GENE SYNTHESIS MARKET BY END-USER

9.1. Introduction

9.2. Pharmaceuticals and Biopharmaceutical Companies

9.3. Contract Research Organisations (CROs)

9.4. Academic & Research Institutes

9.5. Diagnostics Laboratories

9.6. Others

10.  GENE SYNTHESIS MARKET BY GEOGRAPHY

10.1. Introduction

10.2. North America

10.2.1. By Product Type & Service Type

10.2.2. By Technology

10.2.3. By Gene Type

10.2.4. By Application

10.2.5. By End-User

10.2.6. By Country

10.2.6.1. United States

10.2.6.2. Canada

10.2.6.3. Mexico

10.3. South America

10.3.1. By Product Type & Service Type

10.3.2. By Technology

10.3.3. By Gene Type

10.3.4. By Application

10.3.5. By End-User

10.3.6. By Country

10.3.6.1. Brazil 

10.3.6.2. Argentina

10.3.6.3. Others

10.4. Europe

10.4.1. By Product Type & Service Type

10.4.2. By Technology

10.4.3. By Gene Type

10.4.4. By Application

10.4.5. By End-User

10.4.6. By Country

10.4.6.1. United Kingdom

10.4.6.2. Germany

10.4.6.3. France

10.4.6.4. Italy

10.4.6.5. Others

10.5. Middle East & Africa

10.5.1. By Product Type & Service Type

10.5.2. By Technology

10.5.3. By Gene Type

10.5.4. By Application

10.5.5. By End-User

10.5.6. By Country

10.5.6.1. Saudi Arabia

10.5.6.2. UAE

10.5.6.3. Others

10.6. Asia Pacific

10.6.1. By Product Type & Service Type

10.6.2. By Technology

10.6.3. By Gene Type

10.6.4. By Application

10.6.5. By End-User

10.6.6. By Country

10.6.6.1. Japan

10.6.6.2. China

10.6.6.3. India

10.6.6.4. South Korea

10.6.6.5. Taiwan

10.6.6.6. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

11.1. Major Players and Strategy Analysis

11.2. Market Share Analysis

11.3. Mergers, Acquisitions, Agreements, and Collaborations

11.4. Competitive Dashboard

12. COMPANY PROFILES

12.1. Thermo Fisher Scientific Inc.

12.2. Azenta Life Sciences

12.3. GenScript Biotech Corporation

12.4. Eurofins Genomics LLC

12.5. ATUM

12.6. Synbio Technologies LLC

12.7. Epoch Life Science Inc. 

12.8. GCC Biotech Pvt. Ltd.

12.9. Twist Bioscience Corporation

12.10. Integrated DNA Technologies, Inc.

12.11. OriGene Technologies, Inc.

12.12. Biomatik 

13. RESEARCH METHODOLOGY

LIST OF FIGURES

LIST OF TABLES

Companies Profiled

Thermo Fisher Scientific Inc.

Azenta Life Sciences

GenScript Biotech Corporation

Eurofins Genomics LLC

ATUM

Synbio Technologies LLC

Epoch Life Science Inc. 

GCC Biotech Pvt. Ltd.

Twist Bioscience Corporation

Integrated DNA Technologies, Inc.

OriGene Technologies, Inc.

Biomatik 

Related Reports